Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
42 studies found for:    Open Studies | "Papillomavirus Infections"
Show Display Options
Rank Status Study
1 Recruiting Oral Human Papillomavirus Infection in HIV-infected Men
Conditions: Papillomavirus Infections;   HIV Infections
Intervention: Procedure: Oral swabs for HPV-typing and high-risk HPV-determination
2 Recruiting The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
Conditions: Human Papillomavirus Infection;   Genital Warts
Intervention:
3 Recruiting Genital HPV Infections Before and After Renal Transplantation
Condition: Human Papillomavirus Infections
Intervention:
4 Not yet recruiting Lubricant Investigation in Men to Inhibit Transmission of HPV Infection
Condition: Human Papillomavirus Infection
Interventions: Other: Carrageenan-based gel;   Other: Control gel
5 Unknown  Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Conditions: Neoplasms, Squamous Cell;   Papillomavirus Infections
Intervention:
6 Recruiting Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation
Conditions: Infertility;   Sub-fertility;   Papillomavirus Infections
Intervention:
7 Unknown  Human Papillomavirus (HPV) Infection in Pregnancy
Conditions: Papillomavirus Infections;   Pregnancy Complications
Intervention:
8 Unknown  Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Conditions: Papillomavirus Infections;   Warts;   Condylomata Acuminata;   Epidermodysplasia Verruciformis
Interventions: Other: PURELL VF481;   Other: Placebo Comparator
9 Not yet recruiting Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix
Conditions: Uterine Cervical Dysplasia;   Papillomavirus Infections
Interventions: Drug: AV2;   Drug: Placebo
10 Recruiting Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men
Conditions: HIV Infections;   Papillomavirus Infections;   Anal Intraepithelial Neoplasia
Intervention: Behavioral: Smear and biopsy testing for HPV-types and viral load
11 Recruiting Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
Conditions: Human Papillomavirus Infection;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage IVA Laryngeal Squamous Cell Carcinoma;   Stage IVA Laryngeal Verrucous Carcinoma;   Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma;   Stage IVA Major Salivary Gland Carcinoma;   Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVA Oral Cavity Verrucous Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Laryngeal Squamous Cell Carcinoma;   Stage IVB Laryngeal Verrucous Carcinoma;   Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma;   Stage IVB Major Salivary Gland Carcinoma;   Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVB Oral Cavity Verrucous Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Tongue Carcinoma
Interventions: Drug: Veliparib;   Other: Placebo;   Drug: Cisplatin;   Drug: Fluorouracil;   Radiation: Radiation Therapy;   Drug: Hydroxyurea;   Drug: Paclitaxel;   Drug: Carboplatin
12 Recruiting Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Conditions: Human Papillomavirus Infection;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: Docetaxel;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Hyperfractionation;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis
13 Recruiting CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Conditions: Atypical Endocervical Glandular Cell of Undetermined Significance;   Atypical Endometrial Hyperplasia;   Human Papillomavirus Infection;   Stage 0 Cervical Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
14 Unknown  Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
Conditions: Anogenital Warts;   Condylomata Acuminata;   Human Papillomavirus Infection
Interventions: Drug: AP611074;   Drug: Placebo
15 Recruiting CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers
Conditions: Breast Carcinoma;   Cervical Carcinoma;   Colorectal Carcinoma;   Health Status Unknown;   Human Papillomavirus Infection;   Malignant Neoplasm
Intervention: Other: Informational Intervention
16 Recruiting Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma;   Human Papillomavirus Infection;   Recurrent Cervical Carcinoma;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis
17 Recruiting Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study
Condition: Human Papillomavirus Infection
Interventions: Biological: HPV vaccine, Gardasil;   Biological: Hepatitis A vaccine
18 Unknown  e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses
Conditions: Cervical Cancer;   Human Papilloma Virus Infection
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
19 Not yet recruiting Community-Driven Cervical Cancer Prevention in Western Kenya
Conditions: Human Papilloma Virus Infection;   Carcinoma in Situ of Uterine Cervix
Interventions: Behavioral: Community-based testing with standard linkage to care;   Behavioral: Community-based HPV testing with enhanced linkage to care
20 Recruiting Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Verrucous Carcinoma of the Larynx
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Radiation: intensity-modulated radiation therapy;   Procedure: quality-of-life assessment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years